Kyu-Don Kim

Corporate Officer/Principal en GENEXINE, INC. .

66 años

Health Technology

Consumer Services

Perfil

Kyu-Don Kim is currently the Director of Operations at PT Kalbe Genexine Biologics and the President of the Executive Board at Genexine, Inc. Previously, he worked as the Vice President, Director, and Head of Management at Chong Kun Dang Pharmaceutical Corp.
in 2014.
He holds a doctorate degree from Northern Illinois University.

Cargos activos de Kyu-Don Kim

Empresas	Cargo	Inicio
GENEXINE, INC.	Corporate Officer/Principal	-
PT Kalbe Genexine Biologics PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan.	Director de Operaciones	-

Todos los cargos activos de Kyu-Don Kim

Antiguos cargos conocidos de Kyu-Don Kim.

Empresas	Cargo	Fin
CHONG KUN DANG PHARMACEUTICAL CORP.	Director Ejecutivo	-

Ver el detalle de la experiencia de Kyu-Don Kim.

Formación de Kyu-Don Kim.

Northern Illinois University

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kyu-Don Kim.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
GENEXINE, INC.	Health Technology
CHONG KUN DANG PHARMACEUTICAL CORP.	Health Technology

Empresas privadas	1
PT Kalbe Genexine Biologics PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan.	Health Technology